Drugs / EDTA
last change Apr 2016 re-read 2 minutes ago

EDTA

Developed for
infectious disease
Investigated by
M.D. Anderson Cancer Center · Triax

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01539343 Apr 2013 → Apr 2016 infectious disease M.D. Anderson Cancer Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EDTA “Antimicrobial solution, consisting of minocycline in combination with 30mg/ml of a chelator (EDTA) in 25% ethanol solution (HEAL solution), instilled in central venous catheter...” NCT01539343
Route Other “Antimicrobial solution, consisting of minocycline in combination with 30mg/ml of a chelator (EDTA) in 25% ethanol solution (HEAL solution), instilled in central venous catheter...” NCT01539343